Risk of health-related quality-of-life events and pulmonary toxicities in patients with cancer treated with poly adenosine diphosphate ribose polymerase inhibitors: A meta-analysis of seven phase III trials.

Authors
Category Systematic review
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2018
This article has no abstract
Epistemonikos ID: e16befcbf02e4abe5c45b9d7be1b4aad1a72e745
First added on: Feb 10, 2025